Temple Rock Holdings Inc.

CYNAPSUS ANNOUNCES SIGNING OF MEMORANDUM OF UNDERSTANDING
TORONTO, ONTARIO--(Marketwire - Nov. 29, 2010) -
Cynapsus Therapeutics Inc. ("Cynapsus") (formerly Cannasat Therapeutics Inc.) (TSX VENTURE:CTH) today announced it has executed a binding Memorandum of Understanding with IntelGenx Corp. ("IntelGenx"), its former development partner, whereby IntelGenx will forgive $231,000 of debt owing and agrees to pay a royalty on future sales of the INT0010 (formerly Relivar), a buccal/sublingual formulation of THC (dronabinol) for the symptomatic management of Multiple Sclerosis induced neuropathic pain.. MORE>>